IR Contact

Mikael Widell - Ascelia Pharma

Questions from investors, analysts and journalists, please contact:
Mikael Widell
Tel: +46 703 11 99 60

About us

Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway.

Headquarter is in Malmö, Sweden, and the company’s shares are listed on Nasdaq Stockholm (ticker: ACE)